138 related articles for article (PubMed ID: 11097272)
1. Mobilisation of cadmium by meso- and racemic-2,3-dimercaptosuccinic acid (DMSA) in rats.
Blanusa M; Kostial K; Restek-Samarzija N; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 2000 Oct; 87(4):179-81. PubMed ID: 11097272
[TBL] [Abstract][Full Text] [Related]
2. Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
J Appl Toxicol; 1997; 17(1):71-4. PubMed ID: 9048230
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vivo lead mobilization of meso- and rac-2,3-dimercaptosuccinic acids in albino Wistar rats.
Jones MM; Singh PK; Kostial K; Blanusa M; Piasek M; Restek-Samarozija N
Pharmacol Toxicol; 1997 Apr; 80(4):182-6. PubMed ID: 9140137
[TBL] [Abstract][Full Text] [Related]
4. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1997 Nov; 81(5):242-4. PubMed ID: 9396091
[TBL] [Abstract][Full Text] [Related]
5. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models.
Fang X; Hua F; Fernando Q
Chem Res Toxicol; 1996; 9(1):284-90. PubMed ID: 8924605
[TBL] [Abstract][Full Text] [Related]
6. Combined early treatment with chelating agents DMSA and CaDTPA in acute oral cadmium exposure.
Sarić MM; Blanusa M; Juresa D; Sarić M; Varnai VM; Kostial K
Basic Clin Pharmacol Toxicol; 2004 Mar; 94(3):119-23. PubMed ID: 15049341
[TBL] [Abstract][Full Text] [Related]
7. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK
J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263
[TBL] [Abstract][Full Text] [Related]
8. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
[TBL] [Abstract][Full Text] [Related]
9. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats.
Blanusa M; Kostial K; Piasek M; Jones MM; Singh PK
Analyst; 1995 Mar; 120(3):951-3. PubMed ID: 7741262
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated liposomes as carriers for targeting meso-2,3-dimercaptosuccinic acid to cadmium storage sites in cadmium exposed mice.
Behari JR; Nihal (nee Misra) M
Ind Health; 2000 Oct; 38(4):408-12. PubMed ID: 11061485
[TBL] [Abstract][Full Text] [Related]
11. Meso-2,3-dimercaptosuccinic acid and sodium N-benzyl-N-dithiocarboxy-D-glucamine as antagonists for cadmium intoxication.
Jones MM; Basinger MA; Topping RJ; Gale GR; Jones SG; Holscher MA
Arch Toxicol; 1988 Aug; 62(1):29-36. PubMed ID: 2847690
[TBL] [Abstract][Full Text] [Related]
12. Effect of dimercaptosuccinate on the accumulation and distribution of cadmium in the liver and kidney of the rat.
Mason R
Biochem Pharmacol; 1981 Sep; 30(17):2427-33. PubMed ID: 21043241
[TBL] [Abstract][Full Text] [Related]
13. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
Saxena G; Pathak U; Flora SJ
Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
[TBL] [Abstract][Full Text] [Related]
14. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
Bhadauria S; Flora SJ
Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
[TBL] [Abstract][Full Text] [Related]
15. Mobilization and detoxification of polonium-210 in rats by 2,3-dimercaptosuccinic acid and its derivatives.
Rencová J; Volf V; Jones MM; Singh PK
Int J Radiat Biol; 2000 Oct; 76(10):1409-15. PubMed ID: 11057750
[TBL] [Abstract][Full Text] [Related]
16. Mobilization of cadmium in mice by combined treatment with N-benzyl-N-dithiocarboxy-D-glucamine and diesters of meso-2, 3-dimercaptosuccinic acid.
Gale GR; Atkins LM; Smith AB; Singh PK; Jones MM
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):327-37. PubMed ID: 2855182
[TBL] [Abstract][Full Text] [Related]
17. Antidotal effects of 2,3-dimercaptopropane-1-sulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the organotoxicity of dibutyltin dichloride (DBTC) in rats.
Merkord J; Weber H; Kröning G; Hennighausen G
Hum Exp Toxicol; 2000 Feb; 19(2):132-7. PubMed ID: 10773844
[TBL] [Abstract][Full Text] [Related]
18. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats.
Flora SJ; Mehta A; Rao PV; Kannan GM; Bhaskar AS; Dube SN; Pant BP
Toxicology; 2004 Feb; 195(2-3):127-46. PubMed ID: 14751669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
